Advertisement

Picture Berlin Partner Voices Peter Seeberger Chemistry Transformation 650x100px
Document › Details

CRISPR Therapeutics AG. (11/8/17). "Press Release: CRISPR Therapeutics Announces Third Quarter 2017 Financial Results and Provides Business Update". Zug & Cambridge, MA.

Organisations Organisation CRISPR Therapeutics AG (Nasdaq: CRSP)
  Group CRISPR Therapeutics (Group)
  Organisation 2 MaSTherCell S.A. (Manufacturing Synergies for Therapeutic Cells)
  Group Catalent (Group)
Products Product CRISPR gene editing technology
  Product 2 CTX101 (CRISPR Therapeutics)
Persons Person Kulkarni, Samarth (Sam) (CRISPR Therapeutics 201712– promoted CEO before CBO)
  Person 2 Ho, Tony (CRISPR Therapeutics 201708– EVP + Head RnD)
     


   
Record changed: 2023-06-05

Advertisement

Picture EBD Group World of Partnering Opportunities 650x200px

More documents for CRISPR Therapeutics (Group)


To subscribe to our free, monthly newsletter for the European life sciences, please send an e-mail to info@iito.de and simply fill the subject line with the word »LSE Newsletter«

Find more infos about advertising at [iito] web portals in our media flyer [iito] in a Nutshell [PDF file]

Advertisement

Picture Swiss Biotech Association Swiss Biotech Days 2024 SBD24 Basel 650x300px




» top